BORRBangladesh Open Research Repository
SearchSubmitAboutContact
BORRResearch for a Better Bangladesh.
AboutSubmit PaperContactTermsPolicyGitHub

© 2026 Bangladesh Open Research Repository.

Filters

Sort By

Sort by relevanceSort by dateSort by citations
Year Range
to

Results for “"Rohan Anand"”

2 results

A 2x2 factorial, randomised, open-label trial to determine the clinical and cost- effectiveness of hypertonic saline (HTS 6%) and carbocisteine for airway clearance versus usual care over 52 weeks in adults with bronchiectasis: A protocol for the CLEAR clinical trial

Verified

Judy Bradley, Rohan Anand, Brenda O’Neill, Kathryn M. Ferguson et al.

Journal: Research SquareYear: 2019

Abstract Background: Current guidelines for the management of bronchiectasis (BE) highlight the lack of evidence to recommend mucoactive agents, such as hypertonic saline (HTS) and carbocisteine, to aid sputum-removal as part of standard care. We hypothesise that mucoactive agents (HTS or cabocistei...

Health SciencesMedicinePulmonary and Respiratory MedicineOpen Access
Read Source

A 2x2 factorial, randomised, open-label trial to determine the clinical and cost- effectiveness of hypertonic saline (HTS 6%) and carbocisteine for airway clearance versus usual care over 52 weeks in adults with bronchiectasis: A protocol for the CLEAR clinical trial

Verified

Judy Bradley, Rohan Anand, Brenda O’Neill, Kathryn M. Ferguson et al.

Journal: Research SquareYear: 2019

Abstract Background Current guidelines for the management of bronchiectasis (BE) highlight the lack of evidence to recommend mucoactive agents, such as hypertonic saline (HTS) and carbocisteine, to aid sputum-removal as part of standard care. We hypothesise that mucoactive agents (HTS or cabocistein...

Health SciencesMedicinePulmonary and Respiratory MedicineOpen Access
Read Source
PreviousPage 1 of 1Next